Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation

Autor:	Sairah Ahmed, Sean M. Devlin, Esperanza B. Papadopoulos, James W. Young, Ann A. Jakubowski, Patrick Hilden, Julianne Chen, Borje S. Andersson, Richard E. Champlin, Betul Oran, Miguel-Angel Perales, Gabriela Rondon, Piyanuch Kongtim, Molly Maloy, Craig S. Sauter, Doris M. Ponce, Hugo Castro-Malaspina, Uday R. Popat, Marcos de Lima, Sergio Giralt, Richard J. O'Reilly, Roni Tamari
Rok vydání:	2018
Předmět:	Oncology Transplantation medicine.medical_specialty Allogeneic transplantation business.industry medicine.medical_treatment CD34 Hematology Hematopoietic stem cell transplantation 03 medical and health sciences Transplantation outcomes surgical procedures operative 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine Medicine Disease characteristics In patient Stem cell business 030215 immunology
Zdroj:	Biology of Blood and Marrow Transplantation. 24:1079-1087
ISSN:	1083-8791
Popis:	In this study, we compared transplantation outcomes of allogeneic hematopoietic stem cell transplantation (HSCT) in patients with advanced myelodysplastic syndrome (MDS) who received a CD34+ cell-selected and those who received an unmodified allograft. This analysis initially included 181 patients, 60 who received a CD34+ cell-selected transplant and 121 who received an unmodified transplant. Owing to significant differences in disease characteristics, the analysis was limited to patients with
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::404ea909dd9f6656590c36a2875d9c15 https://doi.org/10.1016/j.bbmt.2018.01.001 Zobrazit plný text záznamu Full Text from ScienceDirect